Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Integra LifeSciences Holdings Corporation (IART) had Non-Operating Income/Expense of $-18.28M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$415.61M |
|
$-484.07M |
|
$206.27M |
|
$209.33M |
|
$928.28M |
|
$-512.67M |
|
|
Non-Operating Income/Expense |
$-18.28M |
$-530.95M |
|
$-530.95M |
|
$-484.07M |
|
$-484.07M |
|
$-484.07M |
|
$-484.07M |
|
$-512.67M |
|
$-473.09M |
|
76.69M |
|
76.69M |
|
$-6.31 |
|
$-6.31 |
|
| Balance Sheet Financials | |
$1.14B |
|
$434.82M |
|
$2.53B |
|
$3.67B |
|
$929.81M |
|
$1.23B |
|
$1.70B |
|
$2.63B |
|
$1.04B |
|
$-765.85M |
|
$1.04B |
|
77.92M |
|
| Cash Flow Statement Financials | |
$-2.34M |
|
$-57.57M |
|
$14.24M |
|
$246.38M |
|
$217.91M |
|
$-28.46M |
|
$7.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
0.54 |
|
1.77 |
|
50.37% |
|
-123.36% |
|
-123.36% |
|
-- |
|
-127.75% |
|
-116.47% |
|
$-51.40M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.44 |
|
1.46 |
|
61.61 |
|
-46.61% |
|
63.21% |
|
-13.20% |
|
-21.37% |
|
$13.33 |
|
$-0.67 |
|
$-0.03 |
|